Trial
NCT01591291
Pharmacogenetic Treatments for Alcoholism
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Virginia
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition
Alcoholism
Intervention
Ondansetron + Brief Behavioral Enhancement Treatment
Why stopped
Grant was transferred to University of Maryland and results were reported under NCT02354703.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-20